tirzepatide first month results one week Incredible for this patient on our Medical Weight Loss program. She was 20 months- before and after

Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)

Food lingering longer gives protein more time to break down and release sulfur-smelling gas

Boosts hydration : The moisture equilibrium of the skin is preserved in part by collagen

Mounjaro is the FDA-approved brand-name pen

They are known as spider veins, and they can be caused by age, obesity, excess sun exposure, hormone changes or prolonged inactivity

Eli Lilly and Novartis (speakers bureau